omega-3 fatty acids

Ask MedXY AI

Latest news

Tag

newsclinical trialmajor depressive disorder

Adjunctive Omega-3 Supplementation Does Not Improve Pediatric Major Depressive Disorder: Insights from a Multi-Center Randomized Trial

By MedXY|Jan 6, 2026

A multi-center randomized clinical trial involving 257 youths found that adjunctive omega-3 fatty acids (1.5 g/d) did not outperform placebo in treating moderate-to-severe pediatric major depressive disorder, despite high adherence and conc

Allergy & Immunologylong-term outcomesmultiple sclerosis

Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression: Insights from the BENEFIT Study

By MedXY|Oct 4, 2025

Higher baseline serum alpha-linolenic acid levels predict reduced multiple sclerosis activity, relapses, and disability progression up to 11 years post clinical onset in a large prospective study.

Clinical Updatesomega-3 fatty acids

Synergistic Impact of Probiotic and Omega-3 Supplementation Combined with Ultra-Short Race Pace Training on Sprint Swimming Performance

By MedXY|Oct 3, 2025

Combining probiotics and omega-3 supplementation with ultra-short race pace training significantly enhances sprint swimming performance by improving anaerobic capacity, neuromuscular function, and body composition in competitive male swimme